-- 
BioCancell Has Biggest Two-Day Jump Since July on Trial

-- B y   G w e n   A c k e r m a n
-- 
2011-10-05T14:57:16Z

-- http://www.bloomberg.com/news/2011-10-05/biocancell-has-biggest-two-day-jump-since-august-on-cancer-news.html
BioCancell Therapeutics Inc. had its
biggest two-day gain in three months after it began a Phase IIB
trial for its pancreatic-cancer treatment that was fast-tracked
by the U.S. Food and Drug Administration.  The shares rose 4.9 percent to 1.531 shekels at the 4:30
p.m. close in  Tel Aviv , taking its two-day advance to 12
percent, the most since July 10.  To contact the reporter on this story:
Gwen Ackerman in Tel Aviv at 
 gackerman@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  